Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271)

Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):677-81.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / administration & dosage
  • Azacitidine / adverse effects
  • Azacitidine / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / immunology
  • Chlorine / immunology
  • Cyclohexanes / administration & dosage
  • Cyclohexanes / adverse effects
  • Cyclohexanes / analogs & derivatives
  • Cyclohexanes / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Female
  • Humans
  • Injections, Intravenous
  • Menopause
  • Neoplasm Metastasis
  • Nitrobenzenes / immunology
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Remission, Spontaneous
  • Skin Tests

Substances

  • Antineoplastic Agents
  • Cyclohexanes
  • Nitrobenzenes
  • Nitrosourea Compounds
  • Chlorine
  • Cyclophosphamide
  • Azacitidine